Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 14, 2025 • 9:00 AM ET

Date/Time Source News Release
03/07/2025 06:50 AM EST Business Wire NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
01/23/2025 08:00 AM EST Business Wire NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
12/19/2024 09:00 AM EST GlobeNewswire NioBay Presents Its 2024 Year End Report
12/19/2024 06:50 AM EST Business Wire NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
12/09/2024 06:50 AM EST Business Wire NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting
11/28/2024 05:00 PM EST GlobeNewswire NioBay Announces a New Member to Its Board of Directors
11/25/2024 09:00 AM EST GlobeNewswire NioBay Announces Closing of a Private Placement
11/22/2024 04:05 PM EST Business Wire NovaBay Pharmaceuticals to Reconvene Special Meeting of Stockholders on December 18, 2024
11/18/2024 04:30 PM EST GlobeNewswire Start of Pilot-Scale Production Trials and Agreement to Supply Samples to Two Potential Customers
11/15/2024 08:00 AM EST Business Wire Prominent Independent Proxy Advisory Firm ISS Supports NovaBay Pharmaceuticals' Proposals to Authorize the Sale of its Avenova Brand
Page

Additional News

As of June 14, 2025 • 9:00 AM ET

Date/Time Source News Release
05/06/2025 06:25 PM EDT Zacks Brookdale Senior Living (BKD) Reports Q1 Loss, Lags Revenue Estimates
01/31/2025 03:00 PM EST SeekingAlpha Catalyst Watch: Tariff drama, OPEC+, Alphabet and Amazon earnings, Lennar spinoff
12/25/2024 12:00 PM EST Zacks NovaBay Pharmaceuticals (NBY) Upgraded to Buy: Here's Why
11/08/2024 12:01 AM EST SeekingAlpha NovaBay GAAP EPS of -$0.60 misses by $0.30, revenue of $2.44M misses by $0.19M
11/06/2024 04:49 PM EST SeekingAlpha NovaBay accepts higher PRN offer, says Refresh deal no longer superior
11/05/2024 08:15 AM EST Zacks Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates
10/29/2024 09:00 AM EDT SeekingAlpha NovaBay Pharmaceuticals receives unsolicited offer from Refresh Acquisitions
09/20/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Fri, Sep 20, 2024 as of 4:00 pm ET
09/20/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Fri, Sep 20, 2024 as of 10.00 am ET
09/20/2024 08:07 AM EDT SeekingAlpha NovaBay Pharmaceuticals to sell Avenova assets for $9.5M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.